Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer [Phase 2]
A Phase 2 clinical trial is evaluating atezolizumab with etoposide and platinum chemotherapy for small cell bladder cancer and is currently …
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer [Phase 1]
This Phase 1 trial investigates adjuvant concurrent immunotherapy and radiotherapy for bladder cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: JAM3 as a Prognostic Biomarker in Muscle-Invasive Urothelial Carcinoma: Correlation With Therapeutic Response, and Survival Outcomes
This clinical trial update reports on investigating JAM3 as a prognostic biomarker in muscle-invasive urothelial carcinoma (bladder cancer) …
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating 9MW2821 plus toripalimab versus 9MW2821 alone as first-line treatment for locally advanced or metastatic urothelial…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder [Phase 1, Phase 2]
Clinical trial update of intravesical CGC (cabazitaxel, gemcitabine, and cisplatin) for urothelial carcinoma of the bladder, ongoing in Phas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-02-19EMA Authorised: Balversa (Erdafitinib) — Janssen-Cilag International N.V.
The European Medicines Agency authorised Balversa (erdafitinib) for urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Bladder Cancer Adjuvant Radiotherapy Trial [Phase 3]
An ongoing Phase 3 adjuvant radiotherapy trial in bladder cancer (urothelial carcinoma of the bladder) is currently active but not recruitin…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations [Phase 2]
A Phase 2 clinical trial update assessing sapanisertib in patients with locally advanced or metastatic urothelial carcinoma of the bladder w…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder
A completed clinical trial evaluating treatment preferences in Japanese participants with muscle-invasive urothelial carcinoma of the bladde…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder [Phase 1, Phase 2]
Update on a Phase 1/2 trial of durvalumab with radiation followed by adjuvant durvalumab in urothelial carcinoma of the bladder; the study h…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the combination of a PD-1 inhibitor with Clostridium butyricum for urothelial carcinoma of the bladder; cu…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Can VI-RADS/ADC Accurately Stage Bladder Cancer?? [NA]
This clinical trial update discusses evaluating VI-RADS/ADC imaging to stage bladder cancer, with the study currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial update evaluating feasibility of at-home instillation of UGN-102 for low-grade non-muscle invasive bladder cancer. Results wer…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: ALDOA Expression in Bladder Urothelial Carcinoma
A clinical trial update focusing on ALDOA expression in urothelial carcinoma of the bladder; the study is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS other · 2024-06-27Clinical Trial Update: AN0025 and Pembrolizumab Combination in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update announcing AN0025 in combination with pembrolizumab for advanced solid tumors; the study includes several indi…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) [NA]
This clinical trial update describes PreAct, a study evaluating whether preoperative physical activity can be improved by using activity tra…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in recurrent BCG-unresponsive non-muscle invasive bladder cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab for muscle-invasive urothelial bladder carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of tislelizumab in locally advanced or metastatic urothelial bladder cancer has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume [Phase 4]
Phase 4 clinical trial update evaluating the impact of intravesical BCG and gemcitabine on semen quality and testicular volume in urothelial…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 trial update evaluating pembrolizumab in combination with intravesical BCG solution for recurrent non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 clinical trial update evaluating radio-immunotherapy before cystectomy in locally advanced urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer [Phase 2]
Phase 2 trial update investigating a bladder-sparing regimen of tislelizumab plus gemcitabine and cisplatin for PD-L1 positive muscle-invasi…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer [Phase 1, Phase 2]
Clinical trial evaluating adjuvant proton therapy or IMRT for bladder cancer has completed (Phase 1/2).